Literature DB >> 22684570

Implication of reported viral hepatitis incidence rate change in Hubei Province, China, between 2004-2010.

Ying Hu1,2, Chuanhua Yu1,2, Banghua Chen3, Lei Wang4.   

Abstract

This study examined the change of reported incidence rate for viral hepatitis in Hubei province, China, between 2004 to 2010 to provide scientific evidence for viral hepatitis control. Reported viral hepatitis infection cases were queried from Centre for Disease Control of Hubei Province, China. The incidence of viral hepatitis A decreased steadily across the study period. Viral hepatitis B composed 85% of the viral hepatitis cases. When reported incidence rates for chronic hepatitis B increased, the rates of acute and unclassified cases dropped from 2005 to 2010. The reported viral hepatitis B incidence rate for males was around 1.5-2 times higher than for females. The average annual percentage change of reported viral hepatitis B incidence rates was 4%. The same index for viral hepatitis C was 28%. The reported viral hepatitis B incidence rate of people under 20 years old declined over the period. This decrease was mainly attributed to the recent implementation of vaccination plan. Reported incidence rate of viral hepatitis E also rose in those years. Having a better understanding on reported incidence rates of the present surveillance system is important for developing strategies for further prevention of viral hepatitis. In addition, the data showed that a surveillance system that differentiates new and former infected cases will be more effective in providing evidence for disease control.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22684570     DOI: 10.1007/s11596-012-0074-y

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  19 in total

1.  Bringing chronic disease epidemiology and infectious disease epidemiology back together.

Authors:  Bernard C K Choi; Howard Morrison; Tom Wong; Jun Wu; Yong-Ping Yan
Journal:  J Epidemiol Community Health       Date:  2007-09       Impact factor: 3.710

Review 2.  Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.

Authors:  Paul K Nelson; Bradley M Mathers; Benjamin Cowie; Holly Hagan; Don Des Jarlais; Danielle Horyniak; Louisa Degenhardt
Journal:  Lancet       Date:  2011-07-27       Impact factor: 79.321

Review 3.  Pathogenesis, natural history, treatment, and prevention of hepatitis C.

Authors:  T J Liang; B Rehermann; L B Seeff; J H Hoofnagle
Journal:  Ann Intern Med       Date:  2000-02-15       Impact factor: 25.391

Review 4.  Hepatitis D revival.

Authors:  Heiner Wedemeyer
Journal:  Liver Int       Date:  2011-01       Impact factor: 5.828

5.  Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination.

Authors:  Ian T Williams; Susan T Goldstein; Joseph Tufa; Sylvia Tauillii; Harold S Margolis; Francis J Mahoney
Journal:  Pediatr Infect Dis J       Date:  2003-02       Impact factor: 2.129

Review 6.  Global epidemiology of hepatitis C virus infection.

Authors:  Colin W Shepard; Lyn Finelli; Miriam J Alter
Journal:  Lancet Infect Dis       Date:  2005-09       Impact factor: 25.071

Review 7.  [Epidemiology of hepatitis C virus infection].

Authors:  Tatiana Martins; Janaína Luz Narciso-Schiavon; Leonardo de Lucca Schiavon
Journal:  Rev Assoc Med Bras (1992)       Date:  2011 Jan-Feb       Impact factor: 1.209

Review 8.  Secondary prevention of recurrence by interferon therapy after ablation therapy for hepatocellular carcinoma in chronic hepatitis C patients.

Authors:  Toru Ishikawa
Journal:  World J Gastroenterol       Date:  2008-10-28       Impact factor: 5.742

Review 9.  Risk of hepatocellular carcinoma in hepatitis B and prevention through treatment.

Authors:  Morris Sherman
Journal:  Cleve Clin J Med       Date:  2009-05       Impact factor: 2.321

10.  Epidemiology of acute and chronic hepatitis B virus infection in Norway, 1992-2009.

Authors:  Gražina Rimšelienė; Øivind Nilsen; Hilde Kløvstad; Hans Blystad; Preben Aavitsland
Journal:  BMC Infect Dis       Date:  2011-05-26       Impact factor: 3.090

View more
  2 in total

1.  Socioeconomic inequality in Hepatitis B vaccination of rural adults in China.

Authors:  Dawei Zhu; Na Guo; Jian Wang; Stephen Nicholas; Zhen Wang; Guojie Zhang; Luwen Shi; Knut Reidar Wangen
Journal:  Hum Vaccin Immunother       Date:  2017-12-06       Impact factor: 3.452

Review 2.  A review of the burden of hepatitis C virus infection in China, Japan, South Korea and Taiwan.

Authors:  Heather Bennett; Nathalie Waser; Karissa Johnston; Jia-Horng Kao; Young-Suk Lim; Zhong-Ping Duan; Youn-Jae Lee; Lai Wei; Chien-Jen Chen; William Sievert; Yong Yuan; Hong Li
Journal:  Hepatol Int       Date:  2015-06-13       Impact factor: 6.047

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.